Turning Point Therapeutics, Inc.
TPTXDelisted Aug 17, 2022- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001595893
Turning Point Therapeutics, Inc. was delisted on Aug 17, 2022; its insiders filed their last Form 4 on Aug 17, 2022; 209 institutions reported holding it in 13F filings for Q2 2022, worth $3.29B in total; Soros Fund Management was the only superinvestor holding it.
Q3 2022 vs. Q2 2022
How the institutions holding Turning Point Therapeutics, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 209 | 0 | −209 |
| Shares | 43.7M | 0 | −43.7M (−100.0%) |
| Value | $3.29B | $0 | −$3.29B (−100.0%) |
New holders (0)
Institutions that held Turning Point Therapeutics, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
None.
Sold out (209)
Institutions that held Turning Point Therapeutics, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
Showing the largest 100 of 209 by value.